SEC Filing Details

Document Details

Form
Filing Date
Jan 2, 2025
Document Date
Jan 1, 2025
Form Description
Initial filing by director officer or owner of more than ten percent
Filing Group
3,4,5
Company
LAVA Therapeutics N.V.
Issuer
LAVA THERAPEUTICS NV
Filer
WADLINGER MARY E.